PURPOSE PHARMA INTERNATIONAL AB

Italy

All drugs from this manufacturer

  • ATTROGY

    It is used for the treatment of hereditary transthyretin-mediated amyloidosis (stage 1 and stage 2) in adult patients. It is a hereditary disease in which fibers called amyloid fibrils accumulate in tissues and around nerves, causing symptoms such as tingling, numbness, or weakness.

    Dosage form: tablets, film-coated

    Active substance Dosage
    diflunisal -

    ATC: N02BA11